Influence of surrounding vegetation on woodpecker nest tree selection in oak forests of the Upper Midwest, USAADKINS GIESE, Collette L; CUTHBERT, Francesca J.Forest ecology and management. 2003, Vol 179, Num 1-3, pp 523-534, issn 0378-1127, 12 p.Article

Adaptive designs at European Organisation for Research and Treatment of Cancer (EORTC) with a focus on adaptive sample size re-estimation based on interim-effect sizeMAUER, M; COLLETTE, L; BOGAERTS, J et al.European journal of cancer (1990). 2012, Vol 48, Num 9, pp 1386-1391, issn 0959-8049, 6 p.Article

What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: Surrogacy in question?BONNETAIN, F; BOSSET, J. F; METHY, N et al.European journal of cancer (1990). 2012, Vol 48, Num 12, pp 1781-1790, issn 0959-8049, 10 p.Article

Résultats préliminaires de l'essai EORTC 22911 : prostatectomie radicale suivie ou non de radiothérapie postopératoire dans les cancers de la prostate à haut risque de récidive = Preliminary results for EORTC trial 22911 : radical prostatectomy followed by postoperative radiotherapy in prostate cancers with a high risk of progressionBOLLA, M; VAN POPPEL, H; COLLETTE, L et al.Cancer radiothérapie. 2007, Vol 11, Num 6-7, pp 363-369, issn 1278-3218, 7 p.Conference Paper

Serum alpha-fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significanceDE WIT, R; COLLETTE, L; SYLVESTER, R et al.British journal of cancer. 1998, Vol 78, Num 10, pp 1350-1355, issn 0007-0920Article

Radiothérapie hyperfractionnée et accélérée dans les cancers de la tête et du cou : résultats des essais de l'EORTC et impact sur la pratique clinique = Hyperfractionated and accelerated radiotherapy in head and neck cancer : results of the EORTC trials and impact on clinical practiceHORIOT, J. C; BONTEMPS, P; STUSCHKE, D et al.Bulletin du cancer. Radiothérapie. 1996, Vol 83, Num 4, pp 314-320, issn 0924-4212Conference Paper

Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014)MATZINGER, O; ROELOFSEN, F; COLLETTE, L et al.European journal of cancer (1990). 2009, Vol 45, Num 16, pp 2782-2791, issn 0959-8049, 10 p.Article

Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults : The EORTC 22845 randomised trialVAN DEN BENT, M. J; AFRA, D; KARIM, A. B. M. F et al.Lancet (British edition). 2005, Vol 366, Num 9490, pp 985-990, issn 0140-6736, 6 p.Article

Tissue polypeptide-specific antigen (TPS) determinations before and during intermittent maximal androgen blockade in patients with metastatic prostatic carcinomaKIL, P. J. M; GOLDSCHMIDT, H. M. J; WIEGGERS, B. J. A et al.European urology. 2003, Vol 43, Num 1, pp 31-38, issn 0302-2838, 8 p.Article

Flutamide versus prednisone in patients with prostate Cancer symptomatically progressing after androgen-ablative therapy : A phase III study of the European Organization for Research and Treatment of Cancer genitourinary groupFOSSA, S. D; SLEE, P. H. Th; BRAUSI, M et al.Journal of clinical oncology. 2001, Vol 19, Num 1, pp 62-71, issn 0732-183XArticle

Prostate cancer treated by anti-androgens : is sexual function preserved?SCHRÖDER, F. H; COLLETTE, L; DE REIJKE, T. M et al.British journal of cancer. 2000, Vol 82, Num 2, pp 283-290, issn 0007-0920Article

Intensive induction-sequential chemotherapy with BOP/VIP-B compared with Treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor : A randomized Medical Research council/European organization for Research and Treatment of Cancer studyKAYE, S. B; MEAD, G. M; DE PRIJCK, L et al.Journal of clinical oncology. 1998, Vol 16, Num 2, pp 692-701, issn 0732-183XArticle

Long-term follow-up of an EORTC randomized prospective trial comparing intravesical bacille Calmette-Guérin-RIVM and mitomycin C in superficial bladder cancerWITJES, J. A; MEIJDEN, A. P. M. V. D; COLLETTE, L et al.Urology (Ridgewood, NJ). 1998, Vol 52, Num 3, pp 403-410, issn 0090-4295Article

Postbereavement depressive mood and its prebereavement predictors in HIV+ and HIV- gay menFOLKMAN, S; CHESNEY, M; COLLETTE, L et al.Journal of personality and social psychology. 1996, Vol 70, Num 2, pp 336-348, issn 0022-3514Article

The EORTC Genito-Urinary Cancers Group: 35 years of achievements and future strategySYLVESTER, R; COLLETTE, L; BEX, A et al.European journal of cancer. Supplement (1990). 2012, Vol 10, Num 1, pp 58-65, issn 1359-6349, 8 p.Article

Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991MATZINGER, O; DUCLOS, F; COLLETTE, L et al.European journal of cancer (1990). 2009, Vol 45, Num 16, pp 2825-2834, issn 0959-8049, 10 p.Article

Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant _Drostate cancerSTERNBEG, C. N; DUMEZ, H; COLLETTE, L et al.Annals of oncology. 2009, Vol 20, Num 7, pp 1264-1269, issn 0923-7534, 6 p.Article

Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?VRIELING, C; COLLETTE, L; STRUIKMANS, H et al.European journal of cancer (1990). 2003, Vol 39, Num 7, pp 932-944, issn 0959-8049, 13 p.Article

Quality control of radical prostatectomy : a feasibility studyVAN POPPEL, H; COLLETTE, L; KIRKALI, Z et al.European journal of cancer (1990). 2001, Vol 37, Num 7, pp 884-891, issn 0959-8049Article

Impact of the treating institution on survival of Patients with poor-prognosis metastatic nonseminomaCOLLETTE, L; SYLVESTER, R. J; STENNING, S. P et al.Journal of the National Cancer Institute. 1999, Vol 91, Num 10, pp 839-846, issn 0027-8874Article

Validation of the methods of cosmetic assessment after breast-conserving therapy in the EORTC boost versus no boost trialVRIELING, C; COLLETTE, L; VAN DONGEN, J. A et al.International journal of radiation oncology, biology, physics. 1999, Vol 45, Num 3, pp 667-676, issn 0360-3016Article

Radiation dose homogeneity in an EORTC multicenter trial on breast irradiationPTASZYNSKI, A.-M; VAN DEN BOGAERT, W; HORIOT, J.-C et al.Acta oncologica. Supplementum. 1999, Vol 38, Num 13, pp 19-27, issn 1100-1704Article

An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis. Editorial responseELLIS, M; SPENCE, D; KRCMERY, V et al.Clinical infectious diseases. 1998, Vol 27, Num 6, pp 1406-1414, issn 1058-4838Article

Statistical methodology for personalized medicine: New developments at EORTC Headquarters since the turn of the 21^st CenturyCOLLETTE, L; BOGAERTS, J; LITIERE, S et al.European journal of cancer. Supplement (1990). 2012, Vol 10, Num 1, pp 13-19, issn 1359-6349, 7 p.Article

A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974)DAUGAARD, G; SKONECZNA, I; SCHMOLL, H. J et al.Annals of oncology. 2011, Vol 22, Num 5, pp 1054-1061, issn 0923-7534, 8 p.Article